Stability of globin mRNA in terminally differentiating murine erythroleukemia cells - PubMed (original) (raw)
Stability of globin mRNA in terminally differentiating murine erythroleukemia cells
V Volloch et al. Cell. 1981 Feb.
Abstract
The stability of globin mRNA is terminally differentiating MEL cells has been reevaluated. Previously, it had been reported that globin mRNA has a half-life of approximately 17 hr in terminally differentiating MEL cells. We show that the previous measurements of this parameter were confounded by physical instability of differentiating MEL cells. By using culture conditions that physically stabilize end-stage cells we show that the stability of globin mRNA in terminally differentiating MEL cells is equal to the value observed for ribosomal RNA, a half-life greater than 60 hr.
Similar articles
- Terminal differentiation of murine erythroleukemia cells: physical stabilization of end-stage cells.
Volloch V, Housman D. Volloch V, et al. J Cell Biol. 1982 May;93(2):390-4. doi: 10.1083/jcb.93.2.390. J Cell Biol. 1982. PMID: 6954153 Free PMC article. - A change in the stability of globin mRNA during the induction of murine erythroleukemia cells.
Lowenhaupt K, Lingrel JB. Lowenhaupt K, et al. Cell. 1978 Jun;14(2):337-44. doi: 10.1016/0092-8674(78)90119-8. Cell. 1978. PMID: 667945 - Synthesis and turnover of globin mRNA in murine erythroleukemia cells induced with hemin.
Lowenhaupt K, Lingrel JB. Lowenhaupt K, et al. Proc Natl Acad Sci U S A. 1979 Oct;76(10):5173-7. doi: 10.1073/pnas.76.10.5173. Proc Natl Acad Sci U S A. 1979. PMID: 291931 Free PMC article. - Globin mRNA in Friend cells: its structure, function and synthesis.
Curtis PJ. Curtis PJ. Biochim Biophys Acta. 1980 Sep 22;605(3):347-64. doi: 10.1016/0304-419x(80)90016-5. Biochim Biophys Acta. 1980. PMID: 6996728 Review. - Molecular and cellular mechanisms of leukemic hemopoietic cell differentiation: an analysis of the Friend system.
Tsiftsoglou AS, Wong W. Tsiftsoglou AS, et al. Anticancer Res. 1985 Jan-Feb;5(1):81-99. Anticancer Res. 1985. PMID: 3888045 Review.
Cited by
- Canine adipose tissue-derived MSCs engineered with mRNA to overexpress TSG-6 and enhance the anti-inflammatory effects in canine macrophages.
Yun GH, Park SM, Lim GH, Seo KW, Youn HY. Yun GH, et al. Front Vet Sci. 2023 Apr 6;10:1134185. doi: 10.3389/fvets.2023.1134185. eCollection 2023. Front Vet Sci. 2023. PMID: 37089409 Free PMC article. - Lipid-based nucleic acid therapeutics with in vivo efficacy.
Sufian MA, Ilies MA. Sufian MA, et al. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2023 Mar;15(2):e1856. doi: 10.1002/wnan.1856. Epub 2022 Sep 30. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2023. PMID: 36180107 Free PMC article. Review. - Nanomedicines to Deliver mRNA: State of the Art and Future Perspectives.
Gómez-Aguado I, Rodríguez-Castejón J, Vicente-Pascual M, Rodríguez-Gascón A, Solinís MÁ, Del Pozo-Rodríguez A. Gómez-Aguado I, et al. Nanomaterials (Basel). 2020 Feb 20;10(2):364. doi: 10.3390/nano10020364. Nanomaterials (Basel). 2020. PMID: 32093140 Free PMC article. Review. - Optimization of mRNA untranslated regions for improved expression of therapeutic mRNA.
Asrani KH, Farelli JD, Stahley MR, Miller RL, Cheng CJ, Subramanian RR, Brown JM. Asrani KH, et al. RNA Biol. 2018;15(6):756-762. doi: 10.1080/15476286.2018.1450054. Epub 2018 Mar 26. RNA Biol. 2018. PMID: 29578372 Free PMC article. - AUF-1 and YB-1 independently regulate β-globin mRNA in developing erythroid cells through interactions with poly(A)-binding protein.
van Zalen S, Lombardi AA, Jeschke GR, Hexner EO, Russell JE. van Zalen S, et al. Mech Dev. 2015 May;136:40-52. doi: 10.1016/j.mod.2015.02.003. Epub 2015 Feb 23. Mech Dev. 2015. PMID: 25720531 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources